Amy E. Halseth

1.9k total citations
31 papers, 1.5k citations indexed

About

Amy E. Halseth is a scholar working on Physiology, Pharmacology and Cell Biology. According to data from OpenAlex, Amy E. Halseth has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 9 papers in Pharmacology and 9 papers in Cell Biology. Recurrent topics in Amy E. Halseth's work include Adipose Tissue and Metabolism (10 papers), Muscle metabolism and nutrition (9 papers) and Diet and metabolism studies (9 papers). Amy E. Halseth is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Muscle metabolism and nutrition (9 papers) and Diet and metabolism studies (9 papers). Amy E. Halseth collaborates with scholars based in United States, Italy and Portugal. Amy E. Halseth's co-authors include David H. Wasserman, Deanna P. Bracy, Colleen Burns, Erik J. Henriksen, Louis J. Aronne, Christian Weyer, Nicole C. Kesty, Nuwan D. Nanayakkara, Loretta L. Nielsen and Steven R. Smith and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Diabetes Care.

In The Last Decade

Amy E. Halseth

31 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amy E. Halseth United States	20	607	585	558	394	330	31	1.5k
Mónica Imbernón Spain	13	305 0.5×	607 1.0×	497 0.9×	353 0.9×	269 0.8×	15	1.5k
Peter Kühnen Germany	22	397 0.7×	358 0.6×	435 0.8×	294 0.7×	115 0.3×	71	1.5k
Omar Al–Massadi Spain	26	281 0.5×	837 1.4×	360 0.6×	241 0.6×	127 0.4×	58	1.7k
Paul Richards United Kingdom	15	720 1.2×	355 0.6×	543 1.0×	621 1.6×	58 0.2×	23	1.6k
Louise S. Dalbøge Denmark	13	723 1.2×	457 0.8×	374 0.7×	491 1.2×	210 0.6×	20	1.4k
Anthony N. Hollenberg United States	13	759 1.3×	331 0.6×	273 0.5×	329 0.8×	98 0.3×	18	1.4k
Carlos M. Castorena United States	17	112 0.2×	616 1.1×	386 0.7×	179 0.5×	167 0.5×	30	1.2k
Juan Antonio García-Arnés Spain	23	378 0.6×	496 0.8×	233 0.4×	346 0.9×	169 0.5×	54	1.3k
Andreas Lindqvist Sweden	23	501 0.8×	707 1.2×	343 0.6×	492 1.2×	67 0.2×	56	1.7k
Nicola M. Neary United Kingdom	17	603 1.0×	1.0k 1.7×	226 0.4×	371 0.9×	121 0.4×	21	2.1k

Countries citing papers authored by Amy E. Halseth

Since Specialization

Citations

This map shows the geographic impact of Amy E. Halseth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Halseth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Halseth more than expected).

Fields of papers citing papers by Amy E. Halseth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Halseth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Halseth. The network helps show where Amy E. Halseth may publish in the future.

Co-authorship network of co-authors of Amy E. Halseth

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Halseth. A scholar is included among the top collaborators of Amy E. Halseth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Halseth. Amy E. Halseth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halseth, Amy E., T. Brandt, Hana Cho, et al.. (2023). P51 Phase 1/2 study to evaluate AOC 1020 for adult patients with facioscapulohumeral muscular dystrophy: FORTITUDE trial design. Neuromuscular Disorders. 33. S71–S71. 2 indexed citations

Halseth, Amy E., et al.. (2018). Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion. Obesity Science & Practice. 4(2). 141–152. 22 indexed citations

Guerdjikova, Anna I., Brandon Walsh, Kevin Shan, et al.. (2017). Concurrent Improvement in Both Binge Eating and Depressive Symptoms with Naltrexone/Bupropion Therapy in Overweight or Obese Subjects with Major Depressive Disorder in an Open-Label, Uncontrolled Study. Advances in Therapy. 34(10). 2307–2315. 37 indexed citations

Halseth, Amy E., Kevin Shan, Kye Gilder, & John B. Buse. (2017). Effect on Body Weight of Naltrexone/Bupropion in Overweight and Obese Participants with Cardiovascular Risk Factors in a Large Randomized Double-Blind Study. 4(5). 1 indexed citations

Dalton, Michelle, Graham Finlayson, B. Timothy Walsh, et al.. (2017). Early improvement in food cravings are associated with long-term weight loss success in a large clinical sample. International Journal of Obesity. 41(8). 1232–1236. 41 indexed citations

Aronne, Louis J., et al.. (2010). Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial. Obesity. 18(9). 1739–1746. 75 indexed citations

Smith, Steven R., Louis J. Aronne, Colleen Burns, et al.. (2008). Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity. Diabetes Care. 31(9). 1816–1823. 131 indexed citations

Smith, Steven R., John E. Blundell, Colleen Burns, et al.. (2007). Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. American Journal of Physiology-Endocrinology and Metabolism. 293(2). E620–E627. 107 indexed citations

Mari, Andrea, Loretta L. Nielsen, Nuwan D. Nanayakkara, et al.. (2006). Mathematical Modeling Shows Exenatide Improved β-Cell Function in Patients with Type 2 Diabetes Treated with Metformin or Metformin and a Sulfonylurea. Hormone and Metabolic Research. 38(12). 838–844. 58 indexed citations

10.

Yu, Ying, Stuart A. Ross, Amy E. Halseth, et al.. (2005). Role of PYK2 in the development of obesity and insulin resistance. Biochemical and Biophysical Research Communications. 334(4). 1085–1091. 16 indexed citations

11.

Trautmann, Michael, Jens J. Holst, Amy E. Halseth, et al.. (2005). Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 90(11). 5991–5997. 249 indexed citations

12.

Fueger, Patrick T., et al.. (2003). Fiber type-specific determinants ofV_maxfor insulin-stimulated muscle glucose uptake in vivo. American Journal of Physiology-Endocrinology and Metabolism. 284(3). E541–E548. 33 indexed citations

13.

Halseth, Amy E., et al.. (2002). Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations. Biochemical and Biophysical Research Communications. 294(4). 798–805. 58 indexed citations

14.

Halseth, Amy E., Deanna P. Bracy, & David H. Wasserman. (2001). Functional limitations to glucose uptake in muscles comprised of different fiber types. American Journal of Physiology-Endocrinology and Metabolism. 280(6). E994–E999. 44 indexed citations

15.

Halseth, Amy E., Deanna P. Bracy, & David H. Wasserman. (2000). Limitations to basal and insulin-stimulated skeletal muscle glucose uptake in the high-fat-fed rat. American Journal of Physiology-Endocrinology and Metabolism. 279(5). E1064–E1071. 54 indexed citations

16.

Coker, Robert H., et al.. (2000). Glucagon response to exercise is critical for accelerated hepatic glutamine metabolism and nitrogen disposal. American Journal of Physiology-Endocrinology and Metabolism. 279(3). E638–E645. 17 indexed citations

17.

Halseth, Amy E., Deanna P. Bracy, & David H. Wasserman. (1999). Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo. American Journal of Physiology-Endocrinology and Metabolism. 276(1). E70–E77. 86 indexed citations

18.

Wasserman, David H. & Amy E. Halseth. (1998). An Overview of Muscle Glucose Uptake during Exercise. Advances in experimental medicine and biology. 441. 1–16. 39 indexed citations

19.

Halseth, Amy E., et al.. (1998). Regulation of hepatic glutamine metabolism during exercise in the dog. American Journal of Physiology-Endocrinology and Metabolism. 275(4). E655–E664. 9 indexed citations

20.

Halseth, Amy E., et al.. (1997). Effect of physical activity and fasting on gut and liver proteolysis in the dog. American Journal of Physiology-Endocrinology and Metabolism. 273(6). E1073–E1082. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact